Home Data Calendar Blog

SDGR

Tables

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Weighted Average Number Of Diluted Shares Outstanding		72.81	72.71	72.29	NA	71.92	75.06	73.82	NA	71.21	71.16	71.05	NA	70.78	70.58	NA	NA	72.69	NA	NA	NA	44.88	NA	NA
Weighted Average Number Of Shares Outstanding Basic		72.81	72.71	72.29	NA	71.92	71.64	71.47	NA	71.21	71.16	71.05	NA	70.78	70.58	NA	NA	66.34	NA	NA	NA	44.88	NA	NA
Earnings Per Share Basic		-0.52	-0.74	-0.76	-0.43	-0.86	0.06	1.81	-0.39	-0.56	-0.67	-0.48	-0.43	-0.49	-0.49	NA	-0.18	0.06	NA	NA	NA	-0.26	NA	NA
Earnings Per Share Diluted		-0.52	-0.74	-0.76	-0.41	-0.86	0.06	1.75	-0.39	-0.56	-0.67	-0.48	-0.43	-0.49	-0.49	NA	-0.18	0.05	NA	NA	NA	-0.26	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Revenue From Contract With Customer Excluding Assessed Tax		35.29	47.33	36.60	74.13	42.57	35.19	64.78	56.84	36.98	38.47	48.66	46.17	29.85	29.78	32.13	33.03	25.80	23.09	26.17	25.83	19.96	19.01	20.74
Revenues		35.29	47.33	36.60	74.13	42.57	35.19	64.78	56.84	36.98	38.47	48.66	46.17	29.85	29.78	32.13	33.03	25.80	23.09	26.17	25.83	19.96	19.01	20.74
Cost Of Revenue		17.56	16.00	17.71	16.58	18.93	21.38	19.09	18.14	19.78	21.34	20.68	19.81	18.73	17.80	15.96	14.04	10.53	9.51	10.55	10.30	9.25	9.16	7.74
Gross Profit		17.73	31.34	18.89	57.55	23.64	13.81	45.69	38.70	17.20	17.13	27.98	26.36	11.12	11.98	16.16	18.99	15.27	13.58	15.62	15.53	10.71	9.85	13.00
Operating Expenses		86.15	84.06	86.32	87.17	79.83	74.94	76.19	67.24	63.36	60.61	56.63	48.88	45.79	42.32	40.08	35.58	30.72	30.67	27.43	23.37	22.00	23.81	18.62
Research And Development Expense		50.98	50.84	50.61	51.49	46.83	42.70	40.74	34.54	32.88	31.12	27.82	25.14	23.22	21.09	21.45	17.32	17.02	16.66	13.70	11.08	10.35	9.53	8.44
General And Administrative Expense		24.82	23.54	25.54	25.73	23.89	23.22	26.31	23.32	23.32	22.06	22.13	17.76	17.01	15.85	13.39	13.58	9.73	9.65	8.94	6.55	6.46	8.94	5.09
Selling And Marketing Expense		10.35	9.69	10.17	9.95	9.11	9.02	9.14	9.38	7.16	7.43	6.67	5.97	5.56	5.38	5.24	4.67	3.97	4.36	4.79	5.74	5.18	5.34	5.09
Operating Income Loss		-68.42	-52.73	-67.43	-29.62	-56.19	-61.13	-30.50	-28.54	-46.16	-43.47	-28.64	-22.52	-34.67	-30.34	-23.91	-16.58	-15.45	-17.09	-11.80	-7.85	-11.29	-13.96	-5.61
Allocated Share Based Compensation Expense		12.40	12.81	12.22	12.53	12.65	11.77	10.88	10.21	9.86	10.43	9.13	7.46	7.65	7.02	4.37	3.00	3.04	2.73	1.77	0.58	0.56	0.53	0.52
Income Tax Expense Benefit		-0.09	0.08	0.46	-0.84	-2.89	-20.43	26.36	-0.14	0.19	0.03	-0.03	0.27	-0.00	0.07	0.07	0.23	-0.04	0.06	0.09	-0.03	-0.26	-0.05	0.05
Income Taxes Paid Net		0.41	0.26	0.18	0.63	1.28	0.83	0.09	0.33	0.29	0.13	0.04	0.21	0.01	0.10	0.12	0.16	0.08	0.09	0.06	0.05	0.05	-0.02	0.06
Profit Loss		-38.14	-54.05	-54.72	-30.67	-62.02	4.28	129.14	-27.21	-39.86	-47.67	-34.45	-30.71	-35.01	-34.97	-0.52	-11.59	3.29	-4.07	-14.27	-7.14	-11.96	-0.73	-5.85
Net Income Loss		-38.14	-54.05	-54.72	-30.67	-62.02	4.28	129.14	-27.21	-39.85	-47.69	-34.44	-30.71	-35.01	-34.64	-0.03	-11.14	3.85	-3.35	-13.83	-6.77	-11.51	-0.50	-5.79
Comprehensive Income Net Of Tax		-37.36	-54.16	-55.08	-29.90	-61.83	4.49	130.62	-25.90	-40.14	-48.43	-36.45	-31.41	-35.04	-34.65	-0.27	-11.30	3.60	-2.18	-14.28	-6.78	-11.50	-0.48	-5.78

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Assets		669.30	688.37	737.76	802.96	794.15	841.57	838.77	688.59	661.99	687.88	719.54	756.49	762.62	717.33	744.19	746.26	680.12	349.55	349.87	155.27	NA	NA	NA
Liabilities		219.87	214.39	224.06	254.40	230.57	230.34	248.51	240.68	198.86	194.81	188.87	199.40	182.79	111.56	112.41	122.24	49.23	53.40	54.32	57.01	NA	NA	NA
Liabilities And Stockholders Equity		669.30	688.37	737.76	802.96	794.15	841.57	838.77	688.59	661.99	687.88	719.54	756.49	762.62	717.33	744.19	746.26	680.12	349.55	349.87	155.27	NA	NA	NA
Stockholders Equity		449.43	473.98	513.71	548.56	563.58	611.23	590.26	447.89	463.11	493.06	530.67	557.07	579.81	605.75	631.77	624.01	630.88	296.12	295.52	-93.36	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Assets Current		456.40	449.18	493.69	567.80	547.76	591.96	603.73	533.99	524.20	556.87	586.17	625.06	622.02	649.79	675.24	682.98	621.11	307.01	312.81	118.54	NA	NA	NA
Cash And Cash Equivalents At Carrying Value		160.42	108.11	130.24	155.31	249.38	285.96	233.21	90.47	102.82	127.32	117.26	120.27	160.88	117.70	133.12	202.30	210.49	110.38	144.75	25.99	NA	NA	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		170.18	112.34	134.87	161.07	255.61	291.02	237.69	95.72	108.62	130.82	120.76	123.27	163.88	120.70	133.62	202.80	210.99	110.88	145.25	26.49	33.09	44.45	62.18
Marketable Securities Current		228.26	269.18	300.84	307.69	246.91	262.71	294.48	360.61	370.74	382.25	408.27	456.21	436.31	495.89	515.37	440.39	388.49	173.65	143.50	59.84	NA	NA	NA
Accounts Receivable Net Current		13.28	11.85	19.84	65.99	19.88	9.65	46.69	55.95	23.58	18.77	29.32	31.74	11.35	21.36	11.27	31.42	12.29	13.85	16.27	18.68	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Other Assets Noncurrent		5.15	3.60	3.19	6.01	7.41	5.07	6.23	3.31	2.88	1.80	1.33	2.85	3.97	3.38	2.36	2.35	2.21	2.10	2.17	2.34	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Liabilities Current		111.12	99.76	106.51	133.67	105.04	106.80	123.41	108.80	88.82	85.59	85.53	91.21	72.92	70.38	67.62	73.20	39.28	43.05	42.17	45.02	NA	NA	NA
Accounts Payable Current		11.21	8.12	9.97	16.82	10.32	12.43	11.99	9.47	10.92	5.26	9.77	8.08	8.23	5.96	7.22	8.40	4.81	5.52	6.67	3.52	NA	NA	NA
Other Accrued Liabilities Current		7.64	9.72	10.56	12.00	8.54	7.32	8.56	5.51	6.40	9.17	6.89	7.32	4.83	7.29	5.72	2.86	2.20	2.79	3.19	3.82	NA	NA	NA
Contract With Customer Liability Current		41.77	40.80	49.50	56.23	NA	NA	NA	57.93	NA	NA	NA	55.37	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Other Liabilities Noncurrent		0.30	0.42	0.55	0.67	0.71	0.60	0.70	0.80	0.90	1.00	1.40	0.30	0.30	0.30	0.60	0.65	0.60	0.60	0.90	0.90	NA	NA	NA
Operating Lease Liability Noncurrent		103.26	107.13	108.99	111.01	112.72	107.32	104.06	105.48	87.17	88.11	77.35	77.83	77.14	6.43	6.84	7.22	6.76	7.78	NA	8.89	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Stockholders Equity		449.43	473.98	513.71	548.56	563.58	611.23	590.26	447.89	463.11	493.06	530.67	557.07	579.81	605.75	631.77	624.01	630.88	296.12	295.52	-93.36	NA	NA	NA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest		449.43	473.98	513.71	548.56	563.58	611.23	590.26	447.90	463.12	493.07	530.67	557.09	579.82	605.77	631.78	624.02	630.89	296.15	295.55	-93.32	-87.25	-76.55	-76.66
Additional Paid In Capital Common Stock		933.42	920.62	906.19	885.97	871.10	856.91	840.45	828.70	818.01	807.83	797.00	786.96	778.29	769.20	760.57	752.56	748.12	417.03	414.25	11.65	NA	NA	NA
Retained Earnings Accumulated Deficit		-485.32	-447.19	-393.14	-338.42	-307.75	-245.72	-250.00	-379.14	-351.93	-312.08	-264.39	-229.95	-199.24	-164.23	-129.59	-129.56	-118.42	-122.27	-118.92	-105.10	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		0.60	-0.18	-0.07	0.28	-0.49	-0.68	-0.90	-2.38	-3.69	-3.40	-2.66	-0.65	0.04	0.08	0.08	0.32	0.48	0.73	-0.44	0.02	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		12.40	12.81	12.22	NA	12.65	11.77	10.88	NA	9.86	10.43	9.13	NA	7.65	7.02	4.37	NA	3.04	2.73	1.77	NA	0.56	0.53	0.52

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Net Cash Provided By Used In Operating Activities		-33.26	-53.72	-39.28	-37.26	-49.94	-18.44	-31.09	-24.94	-30.36	-24.66	-39.72	-19.74	-10.64	-29.37	-10.92	43.62	-12.03	-9.05	-5.78	-11.27	-5.93	-4.24	-4.62
Net Cash Provided By Used In Investing Activities		90.70	29.58	5.08	-59.61	13.20	67.24	172.20	11.56	7.84	34.32	36.30	-22.09	52.38	14.81	-61.91	-53.24	-215.98	-24.59	-87.91	6.38	-5.66	-38.49	-16.08
Net Cash Provided By Used In Financing Activities		0.39	1.61	8.01	2.33	1.33	4.52	0.87	0.48	0.32	0.40	0.91	1.22	1.44	1.64	3.66	1.43	328.12	-0.73	212.45	-1.72	0.23	25.01	5.17

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Net Cash Provided By Used In Operating Activities		-33.26	-53.72	-39.28	-37.26	-49.94	-18.44	-31.09	-24.94	-30.36	-24.66	-39.72	-19.74	-10.64	-29.37	-10.92	43.62	-12.03	-9.05	-5.78	-11.27	-5.93	-4.24	-4.62
Net Income Loss		-38.14	-54.05	-54.72	-30.67	-62.02	4.28	129.14	-27.21	-39.85	-47.69	-34.44	-30.71	-35.01	-34.64	-0.03	-11.14	3.85	-3.35	-13.83	-6.77	-11.51	-0.50	-5.79
Profit Loss		-38.14	-54.05	-54.72	-30.67	-62.02	4.28	129.14	-27.21	-39.86	-47.67	-34.45	-30.71	-35.01	-34.97	-0.52	-11.59	3.29	-4.07	-14.27	-7.14	-11.96	-0.73	-5.85
Depreciation Depletion And Amortization		1.56	1.40	1.44	1.35	1.27	1.17	1.76	1.14	1.11	1.13	0.97	0.65	0.58	0.73	0.89	1.01	0.89	0.88	0.88	NA	NA	NA	NA
Increase Decrease In Accounts Receivable		1.43	-7.99	-46.15	46.11	10.23	-37.04	-9.26	32.37	4.82	-10.55	-2.94	20.39	-10.01	10.09	-20.15	19.13	-1.56	-2.42	-2.40	6.80	-1.53	0.83	-1.06
Increase Decrease In Accounts Payable		3.50	-1.79	-7.15	6.58	0.55	-2.28	2.47	-1.42	5.54	-4.27	1.33	-0.18	2.26	-1.26	-1.23	3.63	-0.74	-0.11	2.11	-3.62	3.20	-0.91	1.03
Share Based Compensation		12.40	12.81	12.22	12.53	12.65	11.77	10.88	10.21	9.86	10.43	9.13	7.46	7.65	7.02	4.37	3.00	3.04	2.73	1.77	0.58	0.56	0.53	0.52

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Net Cash Provided By Used In Investing Activities		90.70	29.58	5.08	-59.61	13.20	67.24	172.20	11.56	7.84	34.32	36.30	-22.09	52.38	14.81	-61.91	-53.24	-215.98	-24.59	-87.91	6.38	-5.66	-38.49	-16.08
Payments To Acquire Property Plant And Equipment		1.34	1.00	4.09	2.48	4.92	2.43	3.58	1.35	3.00	1.97	1.70	0.96	2.78	2.91	0.51	0.89	0.33	0.48	0.84	0.16	0.29	0.33	1.06

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Net Cash Provided By Used In Financing Activities		0.39	1.61	8.01	2.33	1.33	4.52	0.87	0.48	0.32	0.40	0.91	1.22	1.44	1.64	3.66	1.43	328.12	-0.73	212.45	-1.72	0.23	25.01	5.17

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Revenues		35.29	47.33	36.60	74.13	42.57	35.19	64.78	56.84	36.98	38.47	48.66	46.17	29.85	29.78	32.13	33.03	25.80	23.09	26.17	25.83	19.96	19.01	20.74
Revenue From Contract With Customer Excluding Assessed Tax		35.29	47.33	36.60	74.13	42.57	35.19	64.78	56.84	36.98	38.47	48.66	46.17	29.85	29.78	32.13	33.03	25.80	23.09	26.17	25.83	19.96	19.01	20.74
Bill And Melinda Gates Foundation Trust, Drug Discovery Services, Related Party		0.59	0.42	0.49	NA	0.94	0.60	0.77	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Bill And Melinda Gates Foundation Trust, S W Services, Related Party		0.02	0.06	0.01	NA	0.06	0.09	0.03	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Bristol Myers Squibb, Collaboration And License Agreement		1.10	7.50	1.50	3.20	11.20	0.70	28.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Contribution		3.12	NA	NA	NA	1.80	NA	NA	NA	0.00	1.00	NA	NA	0.00	1.00	NA	0.00	0.00	1.00	NA	NA	NA	NA	NA
Drug Discovery		3.41	11.93	3.18	5.47	13.66	5.84	32.57	9.02	12.31	8.46	15.58	7.61	5.57	5.73	5.79	8.07	2.94	2.19	2.36	8.30	3.84	4.53	2.14
Hosted Software		8.81	8.09	7.18	6.01	5.46	4.45	4.45	4.12	3.91	3.60	3.25	3.09	2.68	2.70	2.60	2.37	2.37	2.31	2.13	1.93	1.86	1.91	1.71
On Premise Software		12.25	18.76	17.62	53.95	13.81	16.81	19.94	33.63	12.58	16.59	21.69	27.30	15.50	14.45	17.36	16.54	15.06	11.11	15.60	10.72	10.30	8.60	13.02
Professional Services		2.04	2.72	2.73	3.00	2.08	2.21	2.07	4.81	3.11	3.87	3.41	3.57	1.70	1.72	2.28	2.20	1.89	2.93	2.54	1.69	0.93	1.12	1.28
Revenue From Contract With Customer Before Contribution		28.76	35.40	33.41	NA	27.10	29.35	32.21	NA	24.67	29.01	NA	NA	24.28	23.05	NA	24.96	22.86	19.90	NA	17.53	16.12	14.48	NA
Software Products And Services		31.88	35.40	33.41	68.66	28.90	29.35	32.21	47.82	24.67	30.01	33.08	38.56	24.28	24.05	26.34	24.96	22.86	20.90	23.81	17.53	16.12	14.48	18.61
Maintenance		5.66	5.84	5.89	5.69	5.75	5.88	5.75	5.25	5.06	4.95	4.73	4.61	4.40	4.18	4.11	3.84	3.54	3.55	3.54	3.18	3.02	2.85	2.59
Drug Discovery		3.41	11.93	NA	NA	13.66	5.84	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Software		31.88	35.40	NA	NA	28.90	29.35	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
US		24.62	30.70	23.30	54.53	33.13	23.96	50.34	38.71	27.47	27.10	30.27	31.99	21.82	19.68	16.91	16.34	17.77	13.14	13.49	15.66	11.15	10.94	9.87
APAC		5.28	8.71	5.50	5.69	5.57	6.24	7.07	6.17	4.89	2.97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EMEA		5.14	7.80	7.20	13.72	3.76	4.83	6.83	11.76	4.42	5.11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Non Us		0.24	0.12	0.60	0.19	0.12	0.16	3.43	-9.86	3.65	3.29	4.19	2.53	2.54	2.95	3.14	2.12	1.85	2.03	2.44	1.73	1.19	1.36	1.76

Plots across concepts

Line plots across dimensions of each concept